PERITONEAL MESOTHELIOMA
Clinical trials for PERITONEAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PERITONEAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets Tough-to-Treat rare cancers
Disease control TerminatedThis study is testing an experimental drug called XmAb20717 in adults with advanced rare cancers that have few treatment options. The main goals are to see if the drug is safe and if it can shrink tumors or slow their growth. The trial is currently suspended and is not enrolling …
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Aerosol chemo trial aims to extend life for inoperable cancer patients
Disease control TerminatedThis study is testing whether adding a new pressurized aerosol chemotherapy (PIPAC) directly into the abdomen, along with standard intravenous chemotherapy, works better than standard IV chemo alone for people with advanced peritoneal mesothelioma who cannot have surgery. The mai…
Matched conditions: PERITONEAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC